Adalta Ltd (1AD) - Cash Flow Conversion Efficiency

Latest as of June 2025: 3.267x

Based on the latest financial reports, Adalta Ltd (1AD) has a cash flow conversion efficiency ratio of 3.267x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.95 Million ≈ $-1.38 Million USD) by net assets (AU$-598.24K ≈ $-423.30K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Adalta Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Adalta Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 1AD total liabilities for a breakdown of total debt and financial obligations.

Adalta Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Adalta Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
FRESH FACTORY B.C. F:Q4Z	N/A
Fobi AI Inc V:FOBI	-0.676x
Armada Berjaya Trans Tbk PT JK:JAYA	0.080x
Intelligent Bio Solutions Inc. NASDAQ:INBS	-0.831x
Xylo Technologies Ltd. NASDAQ:XYLO	-0.007x
ICDS Limited NSE:ICDSLTD	0.021x
Victrex plc LSE:VCT	0.092x
EXPLOITS DISCOVERY CORP. F:634	N/A

Annual Cash Flow Conversion Efficiency for Adalta Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Adalta Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see 1AD market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$-598.24K ≈ $-423.30K	AU$-2.94 Million ≈ $-2.08 Million	4.909x	+289.49%
2024-06-30	AU$2.03 Million ≈ $1.44 Million	AU$-5.26 Million ≈ $-3.72 Million	-2.590x	+3.59%
2023-06-30	AU$1.91 Million ≈ $1.35 Million	AU$-5.13 Million ≈ $-3.63 Million	-2.687x	-253.48%
2022-06-30	AU$5.38 Million ≈ $3.81 Million	AU$-4.09 Million ≈ $-2.89 Million	-0.760x	-1.52%
2021-06-30	AU$6.39 Million ≈ $4.52 Million	AU$-4.78 Million ≈ $-3.38 Million	-0.749x	+52.93%
2020-06-30	AU$3.70 Million ≈ $2.62 Million	AU$-5.89 Million ≈ $-4.17 Million	-1.591x	-104.89%
2019-06-30	AU$7.49 Million ≈ $5.30 Million	AU$-5.82 Million ≈ $-4.12 Million	-0.776x	+19.51%
2018-06-30	AU$4.07 Million ≈ $2.88 Million	AU$-3.93 Million ≈ $-2.78 Million	-0.965x	-100.48%
2017-06-30	AU$7.75 Million ≈ $5.48 Million	AU$-3.73 Million ≈ $-2.64 Million	-0.481x	-334.96%
2016-06-30	AU$10.62 Million ≈ $7.51 Million	AU$-1.17 Million ≈ $-830.93K	-0.111x	+94.35%
2015-06-30	AU$705.89K ≈ $499.46K	AU$-1.38 Million ≈ $-978.16K	-1.958x	+73.76%
2014-06-30	AU$172.82K ≈ $122.28K	AU$-1.29 Million ≈ $-912.79K	-7.465x	-219.41%
2013-06-30	AU$283.92K ≈ $200.89K	AU$-663.54K ≈ $-469.50K	-2.337x	--

About Adalta Ltd

AU:1AD Australia Biotechnology

Market Cap

$6.50 Million

AU$9.18 Million AUD

Market Cap Rank

#27838 Global

#1482 in Australia

Share Price

AU$0.00

Change (1 day)

+0.00%

52-Week Range

AU$0.00 - AU$0.01

All Time High

AU$0.37